NCT04587934

Brief Summary

The goal of this trial is to compare the time to first heart rate displayed for iRes Warmer with ResusView and using iRes Warmer without ResusView when used in the resuscitation (e.g. Cardiopulmonary resuscitation or breathing assistance) of premature newborns (23 to 32+6 weeks gestation).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 14, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2021

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

January 10, 2024

Completed
Last Updated

January 10, 2024

Status Verified

December 1, 2023

Enrollment Period

5 months

First QC Date

October 2, 2020

Results QC Date

November 20, 2023

Last Update Submit

December 19, 2023

Conditions

Keywords

electrocardiogramNeonatal Resuscitationresuscitation of premature infants

Outcome Measures

Primary Outcomes (1)

  • Time to Heart Rate Display in iRes Warmer With Resusview

    Measure time from birth to heart rate displayed on monitor following lead placement

    Birth to 10 minutes of life

Secondary Outcomes (3)

  • Time to First Change in Fraction of Inspired Oxygen

    Birth to 10 minutes of life

  • Time to First Change in Airway Pressure

    Birth to 10 minutes of life

  • Time to Initiation of Positive Pressure Ventilation (PPV)

    Birth to 10 minutes of life

Other Outcomes (3)

  • Time of Electrode Placement

    Birth to 10 minutes of life

  • EKG Waveform Displayed by Rapid EKG Algorithm During Resuscitation

    Birth to 10 minutes of life

  • Time to Rhythm Recognition

    Birth to 10 minutes of life

Study Arms (2)

iRes Warmer with ResusView

EXPERIMENTAL

iRes Warmer with ResusView program with experimental electrocardiogram monitor will be used for heart rate monitoring in the first 10 minutes of life during routine care and and/or neonatal resuscitation.

Device: iRes Warmer with ResusView

iRes Warmer without ResusView

ACTIVE COMPARATOR

An external non-experimental electrocardiogram monitor will be used for heart rate monitoring in the first 10 minutes of life during routine care and and/or neonatal resuscitation.

Other: iRes Warmer without ResusView

Interventions

Rapid heart rate display utilizing optimized ECG algorithm in iRes Warmer in babies delivered between 23+0 and 32+6 weeks estimated gestational age

Also known as: Panda Bed with ECG Feature
iRes Warmer with ResusView

Electrocardiogram monitoring using external ECG monitor in babies delivered between 23+0 and 32+6 weeks estimated gestational age

Also known as: Standard of Care
iRes Warmer without ResusView

Eligibility Criteria

Age23 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants who are delivered to mothers over the age of 16 years of age
  • Infants delivered at 23+0 to 32+6 weeks estimated gestational age based on the best obstetric estimate at the time of delivery.
  • Infants without known congenital malformations prior to delivery
  • Antenatal consent

You may not qualify if:

  • Infants who are delivered to mothers under the age of 16 years of age
  • Known congenital anomalies of newborn prior to delivery
  • Cardiac defects other than small Ventricular septum defect and Patent ductus arteriosus
  • Multiples
  • Declined consent
  • iRes Warmer with ResusView not available at time of delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sharp Mary Birch Hospital for Women and Newborns

San Diego, California, 92123, United States

Location

Related Publications (4)

  • Katheria A, Arnell K, Brown M, Hassen K, Maldonado M, Rich W, Finer N. A pilot randomized controlled trial of EKG for neonatal resuscitation. PLoS One. 2017 Nov 3;12(11):e0187730. doi: 10.1371/journal.pone.0187730. eCollection 2017.

    PMID: 29099872BACKGROUND
  • Johnson PA, Schmolzer GM. Heart Rate Assessment during Neonatal Resuscitation. Healthcare (Basel). 2020 Feb 23;8(1):43. doi: 10.3390/healthcare8010043.

    PMID: 32102255BACKGROUND
  • Neonatal Resuscitation. Vol. 7th edition. 2016, Elk Grove Village, IL: American Academy of Pediatrics.

    BACKGROUND
  • Katheria AC, Morales A, Shashank S, Rich WD, Finer NN. A Pilot Randomized Trial of Heart Rate Monitoring Using Conventional Versus a New Electrocardiogram Algorithm during Neonatal Resuscitation at Birth. J Pediatr. 2022 Mar;242:245-247.e1. doi: 10.1016/j.jpeds.2021.10.037. Epub 2021 Oct 27.

MeSH Terms

Conditions

Premature Birth

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Dr. Anup Katheria
Organization
Sharp Healthcare

Study Officials

  • Anup Katheria, MD

    Sharp HealthCare

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2020

First Posted

October 14, 2020

Study Start

February 1, 2021

Primary Completion

June 30, 2021

Study Completion

December 10, 2021

Last Updated

January 10, 2024

Results First Posted

January 10, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

Individual participant data, particularly data that underlie the results reported in this article after deidentification will be available with other researchers, including data dictionaries for meta-analysis.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 6 months and ending 36 months following article publication
Access Criteria
Data and publication are available at clinicaltrials.gov
More information

Locations